BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 28306504)

  • 1. Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines.
    Wang X; Goodrich KJ; Gooding AR; Naeem H; Archer S; Paucek RD; Youmans DT; Cech TR; Davidovich C
    Mol Cell; 2017 Mar; 65(6):1056-1067.e5. PubMed ID: 28306504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9orf72 and triplet repeat disorder RNAs: G-quadruplex formation, binding to PRC2 and implications for disease mechanisms.
    Wang X; Goodrich KJ; Conlon EG; Gao J; Erbse AH; Manley JL; Cech TR
    RNA; 2019 Aug; 25(8):935-947. PubMed ID: 31048495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptic RNA-binding by PRC2 components EZH2 and SUZ12.
    Betancur JG; Tomari Y
    RNA Biol; 2015; 12(9):959-65. PubMed ID: 26177152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRC2 direct transfer from G-quadruplex RNA to dsDNA has implications for RNA-binding chromatin modifiers.
    Hemphill WO; Fenske R; Gooding AR; Cech TR
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2220528120. PubMed ID: 37252986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycomb repressive complex 2 binds RNA irrespective of stereochemistry.
    Deckard CE; Sczepanski JT
    Chem Commun (Camb); 2018 Oct; 54(85):12061-12064. PubMed ID: 30295686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous RNA binding by Polycomb repressive complex 2.
    Davidovich C; Zheng L; Goodrich KJ; Cech TR
    Nat Struct Mol Biol; 2013 Nov; 20(11):1250-7. PubMed ID: 24077223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycomb Repressive Complex 2 in Oncology.
    Guo Y; Yu Y; Wang GG
    Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
    Dozmorov MG
    Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved RNA-binding specificity of polycomb repressive complex 2 is achieved by dispersed amino acid patches in EZH2.
    Long Y; Bolanos B; Gong L; Liu W; Goodrich KJ; Yang X; Chen S; Gooding AR; Maegley KA; Gajiwala KS; Brooun A; Cech TR; Liu X
    Elife; 2017 Nov; 6():. PubMed ID: 29185984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
    Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
    J Virol; 2019 May; 93(9):. PubMed ID: 30814291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
    Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBFox2 Binds Nascent RNA to Globally Regulate Polycomb Complex 2 Targeting in Mammalian Genomes.
    Wei C; Xiao R; Chen L; Cui H; Zhou Y; Xue Y; Hu J; Zhou B; Tsutsui T; Qiu J; Li H; Tang L; Fu XD
    Mol Cell; 2016 Jun; 62(6):875-889. PubMed ID: 27211866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-tract RNA removes Polycomb repressive complex 2 from genes.
    Beltran M; Tavares M; Justin N; Khandelwal G; Ambrose J; Foster BM; Worlock KB; Tvardovskiy A; Kunzelmann S; Herrero J; Bartke T; Gamblin SJ; Wilson JR; Jenner RG
    Nat Struct Mol Biol; 2019 Oct; 26(10):899-909. PubMed ID: 31548724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-molecule and in silico dissection of the interaction between Polycomb repressive complex 2 and chromatin.
    Leicher R; Ge EJ; Lin X; Reynolds MJ; Xie W; Walz T; Zhang B; Muir TW; Liu S
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30465-30475. PubMed ID: 33208532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2.
    Davidovich C; Cech TR
    RNA; 2015 Dec; 21(12):2007-22. PubMed ID: 26574518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA.
    Davidovich C; Wang X; Cifuentes-Rojas C; Goodrich KJ; Gooding AR; Lee JT; Cech TR
    Mol Cell; 2015 Feb; 57(3):552-8. PubMed ID: 25601759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
    Shi Y; Ma HL; Zhuang YW; Wang XX; Jiang Y; Xu HE
    Acta Pharmacol Sin; 2019 Nov; 40(11):1457-1465. PubMed ID: 31186533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycomb repressive complex 2 in an autoinhibited state.
    Bratkowski M; Yang X; Liu X
    J Biol Chem; 2017 Aug; 292(32):13323-13332. PubMed ID: 28607149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for inactivation of PRC2 by G-quadruplex RNA.
    Song J; Gooding AR; Hemphill WO; Love BD; Robertson A; Yao L; Zon LI; North TE; Kasinath V; Cech TR
    Science; 2023 Sep; 381(6664):1331-1337. PubMed ID: 37733873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.
    Shivram H; Le SV; Iyer VR
    PLoS One; 2019; 14(9):e0222435. PubMed ID: 31513636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.